Rodman & Renshaw Initiates Coverage On Adial Pharmaceuticals With Buy Rating, Announces Price Target of $8
Rodman & Renshaw Initiates Coverage On Adial Pharmaceuticals With Buy Rating, Announces Price Target of $8
羅德曼與倫肖發起對adial pharmaceuticals的買入評級,宣佈目標價爲8美元
Rodman & Renshaw analyst Brandon Folkes initiates coverage on Adial Pharmaceuticals (NASDAQ:ADIL) with a Buy rating and announces Price Target of $8.
羅德曼與仁善分析師布蘭登·福爾克斯開始對adial pharmaceuticals(納斯達克:ADIL)進行覆蓋,並給予買入評級,目標股價爲8美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。